4 (four) second frenzy is a very cool arcade flash game. You only have 4 seconds to complete each task, so you have to be very quick and prove that your reaction time is very small.

The tasks are random, the instructions appear at the beginning of each task and you can complete each one of them by using the space bar and the arrow keys.

Have Fun !

Click here to play: 4 Second Frenzy

FDA Approves the First Drug for Obese Dogs

The Food and Drug Administration (FDA) today is announcing the approval of Slentrol (dirlotapide), a prescription drug for the management of obesity in dogs. Slentrol reduces appetite and fat absorption to produce weight loss. A veterinarian will determine whether the dog should be treated, based on the dog’s weight and general health.

Veterinarians generally define a dog that weighs 20 percent more than its ideal weight as obese. Surveys have found that approximately 5 percent of dogs in the United States are obese, and another 20-30 percent are overweight.

“This is a welcome addition to animal therapies, because dog obesity appears to be increasing,” said Stephen Sundlof, D.V.M., Ph.D., director of FDA’s Center for Veterinary Medicine. “Veterinarians are well aware that overweight pets are at a higher risk of developing various health problems, from cardiovascular conditions to diabetes to joint problems.”

Slentrol is a new chemical entity, called a selective microsomal triglyceride transfer protein inhibitor, which blocks the assembly and release of lipoproteins into the bloodstream. The mechanism for producing weight loss is not completely understood, but seems to result from reduced fat absorption and a satiety signal from lipid-filled cells lining the intestine.

The drug is given to the dog in varying amounts over the course of the treatment. The dog is given an initial dose for the first 14 days. After that, the veterinarian will assess the dog’s progress at monthly intervals, adjusting the dose depending on the dog’s weight loss. After the dog has achieved the goal weight, the drug’s manufacturer recommends continued use of the drug during a three-month period, while the veterinarian and dog owner establish the optimal level of food intake and physical activity needed to maintain the dog’s weight.

Adverse reactions associated with treatment with Slentrol include vomiting, loose stools, diarrhea, lethargy and loss of appetite.

To discourage human use, the label of Slentrol includes the standard warning, “Not for use in humans. Keep this and all drugs out of reach of children,” and cites adverse reactions associated with human use, including abdominal distention, abdominal pain, diarrhea, flatulence, headache, nausea and vomiting.

Slentrol is manufactured by Pfizer Inc., New York, N.Y.

For more information on Slentrol, please see www.fda.gov/OHRMS/DOCKETS/98fr/2006-141-260-fois001.pdf and www.fda.gov/OHRMS/DOCKETS/98fr/E6-22542.htm .

Behold The Power of Makeup

Scroll down to find out the truth ….

.
.
.
.

.
.
.
.

A series of funny ads by Tuborg - excellent prints with different types of parties

A great put-put game that will definitely keep you busy for a few minutes.

Get the lowest possible score on the round.

This has got to be the funniest laugh in the world!

A new web series called God, Inc is one of the 2007’s first YouTube sensations. Created by Francis Stokes, the show is a comedy about life in the corporate offices of God. What if all the problems on earth were not caused by a spiteful deity, or karma, or fate, but just office politics and the Peter Principle?

Episode 1 of 6: “In The Beginning, There Was Paperwork…” New hire Sarah is given a tour by Brad and meets the Product Development team.

Episode 2 of 6: “The Miracles Department” Austin and Charlie, the last of the Miracles staff, have different ideas about the job.

Episode 3 of 6: “Who Stole God’s Lunch?” Someone steals God’s lunch.

Episode 4 of 6: “And Give Them An 11 AM Deadline On All Species Submissions” Sarah’s first submission goes astray.

Episode 5 of 6: “Beating The Muslims (Not Literally)” The Publicity Department has a sales contest.

… episode 6 to come soon

Blogger forced to flee town after branding it a s***-hole
By PA Mediapoint
Friday, 22 December 2006

A newly appointed manager of a chocolate shop had to flee his job after branding the town a “s***-hole” online.

Steve Beall (pictured) was moved from his home town in the North East to run the new Cafe Thorntons in the shipbuilding town of Barrow-in-Furness, Cumbria, two weeks ago.

But he kept an online diary, or blog, on the popular Myspace.com website - branding his new home “rough and boring”.

After news of his comments became known, locals descended on the shop - and the police had to be called. Beall, 20, has now left his post, and the boss of the chocolate firm has made a grovelling apology to the town.

The young shop manager was moved from his home in Whitley Bay, near Newcastle upon Tyne, and put up in a Travelodge hotel while he helped start up the new shop - but vented his frustrations on MySpace.

Beall, who uses the name “Stevo” online, wrote: “Well then what is there to say about Barrow in Furness apart from its a s***-hole!! “How the hell people live there I’ll never no (sic).

“It’s very rough, give me Newcastle any day and staying in a Travelodge by yourself for over a week is very boring!”.

The manager blasted the town after vandals smashed the shop’s window the day before its official opening on December 8.

Beall wrote: “The first day I was there the little s**** put my shop window through stealing over a grand’s worth of stock!! “I’ve had a few shoplifters which I’m not used to. I’m tired, stressed and need to drink.”

Locals rounded on the manager - and police had to be called after his comments were printed in Barrow’s local paper.

A steady stream of people visited the shop to tell the manager that if he did not like Barrrow he should go elsewhere - or words to that effect.

Others said they would not be visiting the shop again.

Beall’s comments have now been removed from MySpace - and he has been removed from Barrow.

Full Story